WHO Drug Information Vol. 15, No. 2, 2001
(2001; 91 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuPersonal Perspectives
Ouvrir ce répertoire et afficher son contenuReports on Individual Drugs
Fermer ce répertoireVaccines and Biomedicines
Afficher le documentGroup procurement of vaccines
Afficher le documentThe GCC procurement system
Afficher le documentEvaluation of candidate HIV vaccines
Afficher le documentDiagnosis of prion diseases soon possible?
Ouvrir ce répertoire et afficher son contenuCurrent Topics
Ouvrir ce répertoire et afficher son contenuGeneral Information
Ouvrir ce répertoire et afficher son contenuRegulatory and Safety Matters
Ouvrir ce répertoire et afficher son contenuATC/DDD Classification
Ouvrir ce répertoire et afficher son contenuEssential Drugs
Ouvrir ce répertoire et afficher son contenuRecent Publications and Sources of Information
Afficher le documentInternational Nonproprietary Names for Pharmaceutical Substances (INN)
Afficher le documentDénominations communes internationales des Substances pharmaceutiques (DCI)
Afficher le documentDenominaciones Comunes Internacionales para las Sustancias Farmacéuticas (DCI)
Afficher le documentAmendments to previous lists/Modifications apportées aux listes antérieures/Modificaciones a las listas anteriores
Afficher le documentAnnexes
 

Diagnosis of prion diseases soon possible?

Since the appearance of bovine spongiform encephalopathy in 1985, the need for an in vivo diagnostic test for prion diseases has become acute (1). In the absence of such a method, extensive slaughtering of cattle is required once an affected animal has been identified within a herd. Need for such a test has been reinforced since the first cases of variant Creutzfeldt Jakob disease (vCJD) were reported in 1996. vCJD is a fatal neurodegenerative disease believed to be caused by the consumption of BSE contaminated meat, and the incubation time in humans between infection to clinical symptoms may be as along as decades. As opposed to cattle, incubating individuals will be present in society for many years, donating blood and in some cases organs to the non-affected population.

The only known component of the prion (PrPSc) is found mainly in the brains of animals and humans affected with prion diseases. Researchers have now shown (2) that a protease-resistant PrP isoform can be detected in the urine of hamsters, cattle and humans suffering from transmissible spongiform encephalopathies. Most importantly, the isoform was also found in the urine of hamsters inoculated with prions long before the appearance of clinical signs. This finding may therefore pave the way to the diagnosis of humans and animals incubating prion diseases, as well as to increased understanding of the metabolism of PrPSc in vivo. In summary, this research has opened new avenues to investigate the metabolism and clearance mechanisms of PrPSc during prion infection and disease.

References

1. WHO Drug Information, 12(2): 81 (1998).

2. The American Society for Biochemistry and Molecular Biology. Shaked, G. M., Shaked, Y., Kariv, Z et al. A protease resistant PrP isoform is present in urine of animals and humans affected with prion disease. JBP Papers in Press, Manuscript C100278200, 21 June 2001.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013